gemcitabine has been researched along with Cytomegalovirus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, L; Egami, T; Hashizume, M; Matsumoto, K; Mizumoto, K; Nagai, E; Ohuchida, K; Onimaru, M; Tanaka, M; Toma, H | 1 |
| Tan, J; Zhou, X; Zhu, H | 1 |
2 other study(ies) available for gemcitabine and Cytomegalovirus
| Article | Year |
|---|---|
Gemcitabine synergistically enhances the effect of adenovirus gene therapy through activation of the CMV promoter in pancreatic cancer cells.
Topics: Adenoviridae; Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Combined Modality Therapy; Cytomegalovirus; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Genetic Therapy; Genetic Vectors; Hepatocyte Growth Factor; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Promoter Regions, Genetic; Transgenes | 2010 |
hTERT-siRNA could potentiate the cytotoxic effect of gemcitabine to pancreatic cancer cells Bxpc-3.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Colorimetry; Cytomegalovirus; Deoxycytidine; Down-Regulation; Flow Cytometry; G1 Phase Cell Cycle Checkpoints; Gemcitabine; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Telomerase; Time Factors; Transfection | 2012 |